Dr. Gabayan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8900 Wilshire Blvd
Beverly Hills, CA 90211Phone+1 310-432-8900Fax+1 310-432-8901
Education & Training
Olive View/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1998 - 2001
UCLA-VA Greater Los AngelesResidency, Internal Medicine, 1994 - 1997
Keck School of Medicine of the University of Southern CaliforniaClass of 1994
Certifications & Licensure
CA State Medical License 1996 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013
Clinical Trials
- Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC Start of enrollment: 2019 Sep 20
Publications & Presentations
PubMed
- 135 citationsElranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results.Alexander M Lesokhin, Michael H Tomasson, Bertrand Arnulf, Nizar J Bahlis, H Miles Prince
Nature Medicine. 2023-09-01 - 32 citationsA Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab‐Paclitaxel and Gemcitabine in Advanced Solid TumorsGregory L. Beatty, Safi Shahda, Thaddeus Beck, Nikhil Uppal, Steven J. Cohen
The Oncologist. 2019-01-01 - 33 citationsAbdominal Tuberculosis in Patients Infected with the Human Immunodeficiency VirusM J Fee, Maung M. Oo, A E Gabayan, D R Radin, Peter F. Barnes
Clinical Infectious Diseases. 1995-04-01
Press Mentions
Kiromic BioPharma Partners with Beverly Hills Cancer Center for Groundbreaking Lung Cancer Study, USOctober 24th, 2023- Kiromic BioPharma and Beverly Hills Cancer Center Enter Clinical Trial AgreementOctober 25th, 2023
- Kiromic BioPharma Reports Favorable Early Efficacy Results from First Patient in Deltacel-01 Phase 1 Clinical Trial in Non-Small Cell Lung CancerJanuary 30th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
